EUVIMEDEUVIMED entdecken
Crossref

Use of Biosimilars to Infliximab During Pregnancy in Women with Inflammatory Bowel Disease: Results from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO) Study

Uma Mahadevan, Millie D. Long, Dawn Borromeo Beaulieu, Bincy P Abraham, Sunanda V. Kane, Xian Zhang

Carolina Digital Repository (University of North Carolina at Chapel Hill) · 04.12.2024

DOI: 10.17615/s8ge-xh36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carolina Digital Repository (University of North Carolina at Chapel Hill), erschienen am 04.12.2024. Verfasst von Uma Mahadevan und 5 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We aimed to compare pregnancy outcomes of women with inflammatory bowel disease (IBD) utilizing biosimilar vs. originator infliximab (IFX).

Methods

In a prospective cohort of pregnant women with IBD, we collected characteristics, medications, pregnancy outcomes, and developmental milestones. We compared outcomes by IFX biosimilar or originator use via bivariate statistics.

Results

A total of 100 pregnant women on originator IFX and 20 on biosimilar IFX were included. There were no differences in pregnancy complications between groups (48% vs. 35%, p=0.29). Infant developmental milestones were comparable at 12 months.

Conclusions

Biosimilar IFX is not associated with adverse pregnancy or infant outcomes.

Schlagwörter

infliximab biosimilarinflammatory bowel diseasepregnancy outcomespregnancy complicationsneonatal outcomespiano studies

Zitieren

APA

Mahadevan, U., Long, M. D., Beaulieu, D. B., Abraham, B. P., Kane, S. V., & Zhang, X. (2024). Use of Biosimilars to Infliximab During Pregnancy in Women with Inflammatory Bowel Disease: Results from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO) Study. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/s8ge-xh36

Vancouver

Mahadevan U, Long MD, Beaulieu DB, Abraham BP, Kane SV, Zhang X. Use of Biosimilars to Infliximab During Pregnancy in Women with Inflammatory Bowel Disease: Results from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO) Study. Carolina Digital Repository (University of North Carolina at Chapel Hill). 2024. doi:10.17615/s8ge-xh36

BibTeX
@article{Mahadevan2024,
  author = {Mahadevan, Uma and Long, Millie D. and Beaulieu, Dawn Borromeo and Abraham, Bincy P and Kane, Sunanda V. and Zhang, Xian},
  title = {Use of Biosimilars to Infliximab During Pregnancy in Women with Inflammatory Bowel Disease: Results from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes (PIANO) Study},
  journal = {Carolina Digital Repository (University of North Carolina at Chapel Hill)},
  year = {2024},
  doi = {10.17615/s8ge-xh36}
}
Kostenlos starten →